AI assistant
EXELIXIS, INC. — Director's Dealing 2024
May 23, 2024
30561_dirs_2024-05-22_c67057ca-438f-414b-8874-346c4138a42c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2024-05-20
Reporting Person: PAPADOPOULOS STELIOS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-20 | Common Stock | M | 11686 | $19.57 | Acquired | 1272015 | Direct |
| 2024-05-20 | Common Stock | S | 11437 | $21 | Disposed | 1260578 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-20 | Option (right to buy) | $19.57 | M | 11686 | Disposed | 2024-05-24 | Common Stock (11686) | Direct |
Footnotes
F1: Includes 20,718 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.99 to $21.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3: The option, representing the right to purchase a total of 11,686 shares of Exelixis, Inc. common stock, became fully exercisable on May 25, 2017.